Drug intelligence / Profile preview

Argensept

Development stage
Unknown
Lead developer
Zavod Gorizont
Modality
Nanoparticles → Drug Delivery Systems
Administration
Ophthalmic, Topical
01

Overview

Argensept is an ophthalmic antiseptic solution containing silver clusters (nanosilver). It is primarily utilized in Russia for the treatment of inflammatory and infectious diseases of the anterior segment of the eye, including dry eye syndrome, blepharitis, and conjunctivitis. The silver clusters exhibit broad-spectrum antimicrobial activity by interacting with bacterial cell walls, disrupting membrane integrity, and inhibiting essential bacterial enzymes. In clinical practice, Argensept is often used in combination with physiotherapeutic methods such as magnetophoresis to enhance drug penetration and therapeutic efficacy. Recent clinical evaluations have demonstrated its effectiveness in improving tear production and tear film stability in patients with mild to moderate dry eye syndrome.

Brand names
Argensept
Other names
АргенсептSilver clusters solution
02

Targets

Bacterial RibosomeNeuraminidase

Beyond the preview

Go deeper on Argensept.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Argensept.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call